In the midst of much uncertainty, I have some encouraging news from the frontline fight against Coronavirus COVID-19! Hydroxychloriquin, the anti-malarial drug, in conjunction with Azithromycin, is showing great promise in blunting the severe immune reaction created by the virus in causing the lung damage associated with the deadly effects of Coronavirus.
While authorities have not yet had enough time to allow early applications to be studied scientifically against control measures, the early tremendous clinical response by patients has spurred physicians to utilize these medications in their frontline fight against this novel Coronavirus. Certainly the most rigorous science deserves to be pursued in this health crisis, but until other treatments are discovered, we will most likely widely deploy this initial combination of drugs in the current fight against this deadly pathogen, COVID-19.
Legislative measures have been taken to hasten the process of getting new products to those who need them. Instead of awaiting single source testing, U.S. tech companies appear to be able to scale up their testing infrastructure and deploy timely, accurate tests. Turning loose the power of individual companies to use CRISPR Technology has allowed for quickened expansion of nationwide testing. Personal protective equipment is also in heavy demand, and deployment is still awaiting increased manufacture rate, but red tape and bureaucracy have been cut through by federal action at the highest level.
As America’s Best work to find remedies and vaccines, our society must restrict interaction and reduce the passive transmission of this virus. I urge you to stay home, if possible, and also stay in touch with family, friends and neighbors who are elderly and/or immunodeficient, as they truly are the most vulnerable.
